People Keep Using Car Sticker Analogy To Argue For Drug Price Transparency. Here’s Why The Comparison Doesn’t Work.

The common comparison of having increased transparency in drug pricing to forcing car companies to add sticker prices is flawed because it overstates the usefulness of the knowledge by implying that patients have much more power to act — to shop around or negotiate — than they actually do. In other pharmaceutical news: lobbying efforts on Capitol Hill, money for a biotech firm, and a CBO projection on the Senate's drug pricing bill.

from Kaiser Health News https://ift.tt/2JM2vTA